OVARIAN EPITHELIAL CANCER

This adverse event was reported 191 times

These drugs are most commonly taken by patients reporting OVARIAN EPITHELIAL CANCER:

# Drug Count
0 CARBOPLATIN 22
1 METHOTREXATE SODIUM 20
2 METHOTREXATE 19
3 PACLITAXEL 16
4 ADALIMUMAB 15
5 PACLITAXEL (AIBUMIN-BOUND) 14
6 BEVACIZUMAB 13
7 INFLIXIMAB 13
8 MIRVETUXIMAB SORAVTANSINE 13
9 LENALIDOMIDE 10
See all common drugs associated with OVARIAN EPITHELIAL CANCER

OVARIAN EPITHELIAL CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIRVETUXIMAB SORAVTANSINE 13 0.0072
1 HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE 1 0.0047
2 DROSPIRENONE AND ESTRADIOL 1 0.0019
3 CLOMIPHENE CITRATE 1 0.0007
4 DACTINOMYCIN 1 0.0005
5 MEFENAMIC ACID 1 0.0005
6 BEVACIZUMAB-AWWB 2 0.0004
7 IMIGLUCERASE 2 0.0004
8 NEOMYCIN OINTMENT 1 0.0004
9 AMANTADINE HYDROCHLORIDE 2 0.0004
See all drugs enriched for association with OVARIAN EPITHELIAL CANCER